Arun Nagdev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Arun Nagdev has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Jacob Lester Jaremko
Department of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, AB T6G 2T4, Canada
3 shared publications - Brian Buchanan
Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2B7, Canada
2 shared publications - Dornoosh Zonoobi
Exo Imaging, Santa Clara, CA 95054, USA
2 shared publications - Jeevesh Kapur
Department of Diagnostic Imaging, National University of Singapore, Singapore 119074, Singapore
2 shared publications - Mahdiar Nekoui
Exo Imaging, Santa Clara, CA 95054, USA
2 shared publications - Masood Dehghan
Exo Imaging, Santa Clara, CA 95054, USA
2 shared publications
Latest Publications
- Open Access
- 25 August 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (17) , 2145
AI Enhances Lung Ultrasound Interpretation Across Clinicians with Varying Expertise Levels
Background/Objective: Lung ultrasound (LUS) is a valuable tool for detecting pulmonary conditions, but its accuracy depends on user expertise. This study evaluated whether an artificial intelligence (AI) tool could improve clinician performance in detecting pleural effusion and consolidation/atelectasis on LUS scans. Methods: In this multi-reader, multi-case study, 14 clinicians of varying experience reviewed 374 retrospectively selected LUS scans (cine clips from the PLAPS point, obtained using three different probes) from 359 patients across six centers in the U.S. and Canada. In phase one, readers scored the likelihood (0–100) of pleural effusion and consolidation/atelectasis without AI. After a 4-week washout, they re-evaluated all scans with AI-generated bounding boxes. Performance metrics included area under the curve (AUC), sensitivity, specificity, and Fleiss’ Kappa. Subgroup analyses examined effects by reader experience. Results: For pleural effusion, AUC improved from 0.917 to 0.960, sensitivity from 77.3% to 89.1%, and specificity from 91.7% to 92.9%. Fleiss’ Kappa increased from 0.612 to 0.774. For consolidation/atelectasis, AUC rose from 0.870 to 0.941, sensitivity from 70.7% to 89.2%, and specificity from 85.8% to 89.5%. Kappa improved from 0.427 to 0.756. Conclusions: AI assistance enhanced clinician detection of pleural effusion and consolidation/atelectasis in LUS scans, particularly benefiting less experienced users.
- 25 August 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (17) , 2145
Open AccessAI Enhances Lung Ultrasound Interpretation Across Clinicians with Varying Expertise Levels
Background/Objective: Lung ultrasound (LUS) is a valuable tool for detecting pulmonary conditions, but its accuracy depends on user expertise. This study evaluated whether an artificial intelligence (AI) tool could improve clinician performance in detecting pleural effusion and consolidation/atelectasis on LUS scans. Methods: In this multi-reader, multi-case study, 14 clinicians of varying experience reviewed 374 retrospectively selected LUS scans (cine clips from the PLAPS point, obtained using three different probes) from 359 patients across six centers in the U.S. and Canada. In phase one, readers scored the likelihood (0–100) of pleural effusion and consolidation/atelectasis without AI. After a 4-week washout, they re-evaluated all scans with AI-generated bounding boxes. Performance metrics included area under the curve (AUC), sensitivity, specificity, and Fleiss’ Kappa. Subgroup analyses examined effects by reader experience. Results: For pleural effusion, AUC improved from 0.917 to 0.960, sensitivity from 77.3% to 89.1%, and specificity from 91.7% to 92.9%. Fleiss’ Kappa increased from 0.612 to 0.774. For consolidation/atelectasis, AUC rose from 0.870 to 0.941, sensitivity from 70.7% to 89.2%, and specificity from 85.8% to 89.5%. Kappa improved from 0.427 to 0.756. Conclusions: AI assistance enhanced clinician detection of pleural effusion and consolidation/atelectasis in LUS scans, particularly benefiting less experienced users.
- Open Access
- 12 November 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (22) , 2526
Enhancing Lung Ultrasound Diagnostics: A Clinical Study on an Artificial Intelligence Tool for the Detection and Quantification of A-Lines and B-Lines
Background/Objective: A-lines and B-lines are key ultrasound markers that differentiate normal from abnormal lung conditions. A-lines are horizontal lines usually seen in normal aerated lungs, while B-lines are linear vertical artifacts associated with lung abnormalities such as pulmonary edema, infection, and COVID-19, where a higher number of B-lines indicates more severe pathology. This paper aimed to evaluate the effectiveness of a newly released lung ultrasound AI tool (ExoLungAI) in the detection of A-lines and quantification/detection of B-lines to help clinicians in assessing pulmonary conditions. Methods: The algorithm is evaluated on 692 lung ultrasound scans collected from 48 patients (65% males, aged: 55 ± 12.9) following their admission to an Intensive Care Unit (ICU) for COVID-19 symptoms, including respiratory failure, pneumonia, and other complications. Results: ExoLungAI achieved a sensitivity of 91% and specificity of 81% for A-line detection. For B-line detection, it attained a sensitivity of 84% and specificity of 86%. In quantifying B-lines, the algorithm achieved a weighted kappa score of 0.77 (95% CI 0.74 to 0.80) and an ICC of 0.87 (95% CI 0.85 to 0.89), showing substantial agreement between the ground truth and predicted B-line counts. Conclusions: ExoLungAI demonstrates a reliable performance in A-line detection and B-line detection/quantification. This automated tool has greater objectivity, consistency, and efficiency compared to manual methods. Many healthcare professionals including intensivists, radiologists, sonographers, medical trainers, and nurse practitioners can benefit from such a tool, as it assists the diagnostic capabilities of lung ultrasound and delivers rapid responses.
- 12 November 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (22) , 2526
Open AccessEnhancing Lung Ultrasound Diagnostics: A Clinical Study on an Artificial Intelligence Tool for the Detection and Quantification of A-Lines and B-Lines
Background/Objective: A-lines and B-lines are key ultrasound markers that differentiate normal from abnormal lung conditions. A-lines are horizontal lines usually seen in normal aerated lungs, while B-lines are linear vertical artifacts associated with lung abnormalities such as pulmonary edema, infection, and COVID-19, where a higher number of B-lines indicates more severe pathology. This paper aimed to evaluate the effectiveness of a newly released lung ultrasound AI tool (ExoLungAI) in the detection of A-lines and quantification/detection of B-lines to help clinicians in assessing pulmonary conditions. Methods: The algorithm is evaluated on 692 lung ultrasound scans collected from 48 patients (65% males, aged: 55 ± 12.9) following their admission to an Intensive Care Unit (ICU) for COVID-19 symptoms, including respiratory failure, pneumonia, and other complications. Results: ExoLungAI achieved a sensitivity of 91% and specificity of 81% for A-line detection. For B-line detection, it attained a sensitivity of 84% and specificity of 86%. In quantifying B-lines, the algorithm achieved a weighted kappa score of 0.77 (95% CI 0.74 to 0.80) and an ICC of 0.87 (95% CI 0.85 to 0.89), showing substantial agreement between the ground truth and predicted B-line counts. Conclusions: ExoLungAI demonstrates a reliable performance in A-line detection and B-line detection/quantification. This automated tool has greater objectivity, consistency, and efficiency compared to manual methods. Many healthcare professionals including intensivists, radiologists, sonographers, medical trainers, and nurse practitioners can benefit from such a tool, as it assists the diagnostic capabilities of lung ultrasound and delivers rapid responses.
- Open Access
- 8 August 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (16) , 1719
Assessment of an Artificial Intelligence Tool for Estimating Left Ventricular Ejection Fraction in Echocardiograms from Apical and Parasternal Long-Axis Views
This work aims to evaluate the performance of a new artificial intelligence tool (ExoAI) to compute the left ventricular ejection fraction (LVEF) in echocardiograms of the apical and parasternal long axis (PLAX) views. We retrospectively gathered echocardiograms from 441 individual patients (70% male, age: 67.3 ± 15.3, weight: 87.7 ± 25.4, BMI: 29.5 ± 7.4) and computed the ejection fraction in each echocardiogram using the ExoAI algorithm. We compared its performance against the ejection fraction from the clinical report. ExoAI achieved a root mean squared error of 7.58% in A2C, 7.45% in A4C, and 7.29% in PLAX, and correlations of 0.79, 0.75, and 0.89, respectively. As for the detection of low EF values (EF < 50%), ExoAI achieved an accuracy of 83% in A2C, 80% in A4C, and 91% in PLAX. Our results suggest that ExoAI effectively estimates the LVEF and it is an effective tool for estimating abnormal ejection fraction values (EF < 50%). Importantly, the PLAX view allows for the estimation of the ejection fraction when it is not feasible to acquire apical views (e.g., in ICU settings where it is not possible to move the patient to obtain an apical scan).
- 8 August 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (16) , 1719
Open AccessAssessment of an Artificial Intelligence Tool for Estimating Left Ventricular Ejection Fraction in Echocardiograms from Apical and Parasternal Long-Axis Views
This work aims to evaluate the performance of a new artificial intelligence tool (ExoAI) to compute the left ventricular ejection fraction (LVEF) in echocardiograms of the apical and parasternal long axis (PLAX) views. We retrospectively gathered echocardiograms from 441 individual patients (70% male, age: 67.3 ± 15.3, weight: 87.7 ± 25.4, BMI: 29.5 ± 7.4) and computed the ejection fraction in each echocardiogram using the ExoAI algorithm. We compared its performance against the ejection fraction from the clinical report. ExoAI achieved a root mean squared error of 7.58% in A2C, 7.45% in A4C, and 7.29% in PLAX, and correlations of 0.79, 0.75, and 0.89, respectively. As for the detection of low EF values (EF < 50%), ExoAI achieved an accuracy of 83% in A2C, 80% in A4C, and 91% in PLAX. Our results suggest that ExoAI effectively estimates the LVEF and it is an effective tool for estimating abnormal ejection fraction values (EF < 50%). Importantly, the PLAX view allows for the estimation of the ejection fraction when it is not feasible to acquire apical views (e.g., in ICU settings where it is not possible to move the patient to obtain an apical scan).